5-(morpholin-4-ylmethyl)isoxazole-3-carboxylic acid hydrochloride, 1g

2-diazenyl-2-hydroxy-N-(pyridin-2-yl)acetamide, 95%, 2.5g

1-(Bromomethyl)-4-ethylbenzene, 95.0%, 100mg

Volumetric flasks with screw cap, class A transparent, 50 ml, 2 Piece(s)

4-CHLORO-1-(2,4-DIMETHYLPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 95.0%, 250mg

4-(5-Methylpyridin-2-yl)benzaldehyde, 97%, 1g

(R)-3-(((9H-Fluoren-9-yl)methyl)thio)-2-(((allyloxy)carbonyl)amino)propanoic acid, 97%, 5g

N-(5-Chloro-2-hydroxyphenyl)acetamide, 95.0%, 5g

Triethyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate, 97%, 5g

4-(2-Bromoacetyl)benzonitrile, 97.0%, 25g

(3,4-Bis(methoxycarbonyl)phenyl)boronic acid, 95.0%, 5g

2-(Methoxycarbonyl)nicotinic acid, 97.0%, 1g

1,3-Bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholidine 2-Oxide, 97%, 5g